RxDoctor Payments Data

Ian Barron, DPM

Foot & Ankle Surgery · San Antonio, TXNPI 1124448535

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (57.7%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Kerecis Limited accounts for 89.1% of it on its own, with 38 other manufacturers making up the rest. Among foot & ankle surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$162,080in general payments, 2019–2025

Across 241 payments — averaging $672.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kerecis Limited$144K
  • CDC Medical LLC$3K
  • Stryker$3K
  • Vilex LLC$3K
  • Smith+Nephew$2K
  • Arthrex$2K
  • plus $5K from 33 others

What the payments were for

  • Consulting fees$21,29213%
  • Speaking & faculty fees$93,54158%
  • Travel & lodging$28,21717%
  • Food & beverage$14,3609%
  • Education$4,6703%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$162,080 in reported general payments places this provider in the 95th percentile of 684 foot & ankle surgery providers in Texas.

See all foot & ankle surgery providers in Texas

Medicare billing

Part B allowed, 2024
$16,761
Medicare patients
82
Services billed
187

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip56$1,276
Ammonium Lactate23$514
Ciclopirox12$373
Ketoconazole11$274

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →